Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Dupixent clears PhIII trial in new disease as blockbuster looks to expand past Regeneron-Sanofi split
Endpoints
Wed, 05/27/20 - 10:27 am
Tags:
Dupixent, Sanofi, Regeneron, esosinophilic esophagitis, EoE, clinical trials
Sanofi to Sell Regeneron Stake Worth About $13 Billion
Yahoo/Bloomberg
Mon, 05/25/20 - 11:32 pm
Tags:
Sanofi, Regeneron
Big pharma heads towards important readouts
EP Vantage
Wed, 05/20/20 - 10:22 am
Tags:
Ozempic, Novo Nordisk, etrolizumab, Roche, Ipatasertib, finerenone, Bayer, filgotinib, Gilead Sciences, Galapagos, Avalglucosidase alfa, Sanofi, Rinvoq, AbbVie, clinical trials
COVID-19 vaccine row escalates as Macron calls meeting with Sanofi’s CEO
Pharmaforum
Fri, 05/15/20 - 10:35 am
Tags:
COVID-19, vaccines, Sanofi, France, Paul Hudson, Pharma CEOs
Sanofi nabs speedy review of sutimlimab, aiming for a November approval
Fierce Biotech
Fri, 05/15/20 - 10:19 am
Tags:
Sanofi, cold agglutinin disease, sutimlimab, FDA, priority review
Sanofi CEO courts controversy after saying US is first in line for COVID-19 vaccine
Pharmaforum
Thu, 05/14/20 - 10:13 am
Tags:
Sanofi, Pharma CEOs, Paul Hudson, COVID-19, vaccines
Sanofi takes aim at J&J's myeloma star Darzalex with latest Sarclisa trial win
Fierce Pharma
Tue, 05/12/20 - 12:01 pm
Tags:
Sanofi, Sarclisa, Multiple Myeloma, Amgen, Kyprolis
Former Sanofi research exec Zerhouni favorite for COVID-19 czar: report
Fierce Biotech
Mon, 05/11/20 - 10:29 am
Tags:
COVID-19, vaccines, NIH, Sanofi, Elias Zerhouni
Sanofi and Regeneron's I-O med Libtayo, on a roll, puts up basal cell carcinoma win
Fierce Pharma
Tue, 05/5/20 - 12:59 pm
Tags:
Sanofi, Regeneron, Libtayo, basal cell carcinoma, skin cancer, clinical trials
Jury still out on IL-6 drugs in COVID-19 following preliminary trial results
Pharmaforum
Tue, 04/28/20 - 10:42 am
Tags:
COVID-19, clinical trials, IL-6, Sanofi, Kevzara, Roche, Actemra
Sanofi CEO cautions arthritis drug a 'long shot' in COVID-19, says study results 'imminent'
BioPharma Dive
Sun, 04/26/20 - 01:47 pm
Tags:
Sanofi, clinical trials, COVID-19, Paul Hudson, Kevzara
FDA Approves Sanofi’s Meningococcal Meningitis Vaccine
BioSpace
Sat, 04/25/20 - 12:16 am
Tags:
FDA, Sanofi, vaccines, MenQuadfi, meningococcal conjugate vaccine, meningococcal disease
Sanofi culls pipeline dud, still looking to out-license unwanted later-stage meds
Fierce Biotech
Fri, 04/24/20 - 10:54 am
Tags:
Sanofi, Regeneron, efpeglenatide, type 2 diabetes
Sanofi posts data from contentious phase 2 multiple sclerosis trial
Fierce Biotech
Thu, 04/23/20 - 09:15 pm
Tags:
Sanofi, clinical trials, MS, multiple sclerosis, Principia Biopharma, SAR442168
Sanofi CEO Hudson continues crusade for European pandemic muscle
Fierce Pharma
Thu, 04/23/20 - 11:04 am
Tags:
Sanofi, vaccines, COVID-19, Pharma CEOs, Paul Hudson, BARDA, Europe
Sanofi links with Luminostics on smartphone coronavirus test
Pharmaforum
Fri, 04/17/20 - 10:50 am
Tags:
Sanofi, devices, diagnostics, Luminostics, smartphones, COVID-19
Sanofi, GSK tie up for COVID-19 vaccine work with eyes on possible 2021 rollout
Fierce Pharma
Tue, 04/14/20 - 10:12 am
Tags:
Sanofi, GSK, vaccines, COVID-19
Aslan's Dupixent rival test put on hold amid COVID-19, but delays shouldn't hit readout
Fierce Biotech
Mon, 04/13/20 - 10:57 am
Tags:
Aslan Pharma, ASLAN004, Regeneron, Sanofi, Dupixent, atopic dermatitis
Pfizer, BioNTech Say mRNA COVID-19 Vaccine Trials May Start This Month
Xconomy
Thu, 04/9/20 - 11:21 pm
Tags:
vaccines, clinical trials, COVID-19, BioNTech, Pfizer, Sanofi, MRNA
With Kevzara in COVID-19 testing, Sanofi and Regeneron won't divvy up their rights
Fierce Pharma
Wed, 04/8/20 - 11:38 pm
Tags:
Sanofi, Regeneron, Paul Hudson, Kevzara, COVID-19

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.